Teruki Sakoh

Kumamoto University

Papers

1

Total Citations

2

H-Index

1

About

Teruki Sakoh is a surgical oncologist whose work centers on the transformative potential of conversion therapy for advanced gastric cancer. His research focuses on achieving pathological complete responses in patients with stage IV disease—a population traditionally considered incurable. In his most-cited study, Sakoh documents a landmark case of a patient with multiple liver metastases who achieved a complete pathological response after treatment with S-1 plus oxaliplatin, followed by conversion surgery. This work highlights his commitment to pushing the boundaries of multimodal treatment, demonstrating that even extensive metastatic disease can be rendered resectable and potentially curable. While his citation count is still growing, the clinical significance of his findings is profound, offering a blueprint for aggressive, personalized management of stage IV gastric cancer. Sakoh’s contributions are particularly notable for bridging chemotherapy and surgical intervention, providing hope for patients with limited options. His research underscores a paradigm shift in oncology: that conversion surgery, guided by robust chemotherapeutic response, can alter the natural history of advanced disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Conversion surgery for stage IV gastric cancer with multiple liver metastases with a complete pathological response to S-1 plus oxaliplatin therapy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Kumamoto University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago